by Uniseed01 | Feb 10, 2017 | Latest News
Auris Medical Expands Clinical Development Pipeline with Intranasal Betahistine for the Treatment of Meniere’s Disease and Vestibular Vertigo – Pipeline strengthens with addition of AM-125 as third clinical-stage program – Acquisition of assets related to...
by Uniseed01 | Feb 7, 2017 | Latest News
Uniseed makes £200,000 investment in Exonate as part of £1.5 million round from existing and new investors Exonate awarded £4.9 million from the Wellcome Trust ‐ Seeding Drug Discovery Initiative Program to develop eye drop treatment for wet age‐related macular...
by Uniseed01 | Feb 7, 2017 | Latest News
Exonate receives Wellcome Trust funding to develop eye drop treatment for wet age-related macular degeneration (wet AMD) Early stage biotechnology company targeting ophthalmology and other areas of unmet medical need Cambridge, UK. Monday 6th February 2017 –...
Recent Comments